TY - JOUR
T1 - Cyclodepsipeptide natural products apratoxins A and C and their analogs
AU - Doi, Takayuki
AU - Masuda, Yuichi
AU - Yoshida, Masahito
N1 - Funding Information:
We deeply thank all co─workers shown in reference 6. This work was supported by Grant─in─Aids from the Ministry of Education, Culture, Sports, Science and Technology, Japan (No. 14103013, No. 17035026, No. 23310145, and No. 26282208) and JSPS KAKENHI Grant JP15H05837 in Middle Molecular Strategy.
Publisher Copyright:
© 2018 Society of Synthetic Organic Chemistry. All rights reserved.
PY - 2018
Y1 - 2018
N2 - In this study, the total syntheses of apratoxins A and C and their analogs were carried out. Apratoxins A and C and their oxazoline analogs exhibited potent cytotoxicities against cancer cells as well as similar 3D structures in solution as analyzed by a distance geometry method. The oxazoline analogs were slightly less, but highly, potent as they exhibited similar conformations as their parent compounds. As the MoCys moiety possibly induced severe toxicity owing to the ability of a Michael acceptor and instability of the thiazoline ring under acidic and basic conditions, MoCys and MeAlaMeIle were substituted by other simple amino acids. In addition, the combinatorial synthesis of these mimetics was carried out by the split and mix method with solidphase peptide synthesis and solutionphase macrolactamization in parallel. Apratoxin M7 in which MoCys was replaced by piperidine4carboxylic acid was found to exhibit a conformation similar to that of apratoxin A, and indicated moderate activity. Based on apratoxin M7, the further optimization of the Tyr(Me) MeAlaMeIle tripeptide led to the discovery of apratoxin M16 (Bph/Tyr(Me)), which is as potent as apratoxin A. The growth inhibitory activity of apratoxin A and apratoxin M16 against 10 cancer cell lines was comparable, suggesting that the target of apratoxin M16 should be the same as that of apratoxin A.
AB - In this study, the total syntheses of apratoxins A and C and their analogs were carried out. Apratoxins A and C and their oxazoline analogs exhibited potent cytotoxicities against cancer cells as well as similar 3D structures in solution as analyzed by a distance geometry method. The oxazoline analogs were slightly less, but highly, potent as they exhibited similar conformations as their parent compounds. As the MoCys moiety possibly induced severe toxicity owing to the ability of a Michael acceptor and instability of the thiazoline ring under acidic and basic conditions, MoCys and MeAlaMeIle were substituted by other simple amino acids. In addition, the combinatorial synthesis of these mimetics was carried out by the split and mix method with solidphase peptide synthesis and solutionphase macrolactamization in parallel. Apratoxin M7 in which MoCys was replaced by piperidine4carboxylic acid was found to exhibit a conformation similar to that of apratoxin A, and indicated moderate activity. Based on apratoxin M7, the further optimization of the Tyr(Me) MeAlaMeIle tripeptide led to the discovery of apratoxin M16 (Bph/Tyr(Me)), which is as potent as apratoxin A. The growth inhibitory activity of apratoxin A and apratoxin M16 against 10 cancer cell lines was comparable, suggesting that the target of apratoxin M16 should be the same as that of apratoxin A.
UR - http://www.scopus.com/inward/record.url?scp=85056311359&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85056311359&partnerID=8YFLogxK
U2 - 10.5059/yukigoseikyokaishi.76.1170
DO - 10.5059/yukigoseikyokaishi.76.1170
M3 - Article
AN - SCOPUS:85056311359
SN - 0037-9980
VL - 76
SP - 1170
EP - 1175
JO - Yuki Gosei Kagaku Kyokaishi/Journal of Synthetic Organic Chemistry
JF - Yuki Gosei Kagaku Kyokaishi/Journal of Synthetic Organic Chemistry
IS - 11
ER -